BPC + TB Oral Blend
An oral combination of BPC-157 and TB-500 analogs studied for mucosal absorption and systemic exposure relative to injectable routes. Research focuses on gut-integrity markers, oral bioavailability challenges, and comparative healing endpoints in GI injury models.
For in vitro and laboratory research only. Not for human or veterinary administration. Not evaluated by the FDA.
Variants & Pricing
BB500
Oral500mcg+500mcg × 100 tabs
$150
To request this compound, join Discord and open a ticket with the product code and variant.
Order via Discord